In a diverse cohort of cancer patients, Lyudovyk et al.1 show that persistent COVID-19 infection is associated with weaker humoral responses and increased CD8+ T cell responses that are ineffective in clearing virus, particularly in patients receiving B cell-depleting therapies.

Original languageEnglish
Article number100695
JournalCell Reports Medicine
Issue number7
StatePublished - 19 Jul 2022


Dive into the research topics of 'CD8+ T cells: An ineffective armor against prolonged COVID-19 in cancer patients'. Together they form a unique fingerprint.

Cite this